Fosamax, Zometa, Aredia Injuries

Fosamax, Zometa, and Aredia are in a class of cancer treatment drugs called bisphosphonates.  A disease called osteonecrosis, which involves the breakdown of the jaw bone, has occurred in some cancer patients receiving bisphosphonates.  Some patients have reportedly experienced dental problems so severe they have lost portions of their jaws. 

At the direction of the Food and Drug Administration, in September 2004, Novartis, the maker of Zometa and Aredia, added a precaution to the drugs' labels and sent letters warning doctors that osteonecrosis of the jaw (ONJ) has been reported in patients with cancer receiving treatment regimens including bisphosphonates.  Novartis had received 500 case reports of jaw problems in people taking Aredia and Zometa, according to a December 2004 Wall Street Journal article.

If you believe that you were injured by Fosamax, Zometa, Aredia, or any other drug in the class of drugs called bisphosphonates, please call our lawyers or e-mail our law firm by submitting a Potential Case Form.